Rheumatic Myocarditis: A Poorly Recognized Etiology of Left Ventricular Dysfunction in Valvular Heart Disease Patients

被引:1
|
作者
Rosa, Vitor Emer Egypto [1 ]
Lopes, Mariana Pezzute [1 ]
Spina, Guilherme Sobreira [1 ]
Soares Junior, Jose [1 ]
Salazar, David [1 ]
Romero, Cristhian Espinoza [1 ]
Lottenberg, Marcos Pita [1 ]
de Santis, Antonio [1 ]
Pires, Lucas Jose Neves Tachotti [1 ]
Goncalves, Luis Fernando Tonello [1 ]
Fernandes, Joao Ricardo Cordeiro [1 ]
Sampaio, Roney Orismar [1 ]
Tarasoutchi, Flavio [1 ]
机构
[1] Univ Sao Paulo, Clin Hosp, Heart Inst InCor, Sao Paulo, Brazil
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2021年 / 8卷
关键词
myocarditis; rheumatic fever; rheumatic heart disease; valvular heart disease; heart failure; FEVER; ECHOCARDIOGRAPHY; DIAGNOSIS; CHILDREN; PREVALENCE;
D O I
10.3389/fcvm.2021.676694
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Heart failure occurs in similar to 10% of patients with acute rheumatic fever (RF), and several studies have shown that cardiac decompensation in RF results primarily from valvular disease and is not due to primary myocarditis. However, the literature on this topic is scarce, and a recent case series has shown that recurrent RF can cause ventricular dysfunction even in the absence of valvular heart disease. Methods: The present study evaluated the clinical, laboratory and imaging characteristics of 25 consecutive patients with a clinical diagnosis of myocarditis confirmed by 18F-FDG PET/CT or gallium-67 cardiac scintigraphy and RF reactivation according to the revised Jones Criteria. Patients underwent three sequential echocardiograms at (1) baseline, (2) during myocarditis and (3) post corticosteroid treatment. Patients were divided according to the presence (Group 1) or absence (Group 2) of reduced left ventricular ejection fraction (LVEF) during myocarditis episodes. Results: The median age was 42 (17-51) years, 64% of patients were older than 40 years, and 64% were women. Between Group 1 (n = 16) and in Group 2 (n = 9), there were no demographic, echocardiographic or laboratory differences except for NYHA III/IV heart failure (Group 1: 100.0% vs. Group 2: 50.0%; p = 0.012) and LVEF (30 [25-37] vs. 56 [49-62]%, respectively; p < 0.001), as expected. Group 1 patients showed a significant reduction in LVEF during carditis with further improvement after treatment. There was no correlation between LVEF and valvular dysfunction during myocarditis. Among all patients, 19 (76%) underwent 18F-FDG PET/CT, with a positive scan in 68.4%, and 21 (84%) underwent gallium-67 cardiac scintigraphy, with positive uptake in 95.2%, there was no difference between these groups. Conclusion: Myocarditis due to rheumatic fever reactivation can cause left ventricular dysfunction despite valvular disease, and it is reversible after corticosteroid treatment.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction
    Ammirati, Enrico
    Veronese, Giacomo
    Brambatti, Michela
    Merlo, Marco
    Cipriani, Manlio
    Potena, Luciano
    Sormani, Paola
    Aoki, Tatsuo
    Sugimura, Koichiro
    Sawamura, Akinori
    Okumura, Takahiro
    Pinney, Sean
    Hong, Kimberly
    Shah, Palak
    Braun, Oscar
    Van de Heyning, Caroline M.
    Montero, Santiago
    Petrella, Duccio
    Huang, Florent
    Schmidt, Matthieu
    Raineri, Claudia
    Lala, Anuradha
    Varrenti, Marisa
    Foa, Alberto
    Leone, Ornella
    Gentile, Piero
    Artico, Jessica
    Agostini, Valentina
    Patel, Rajiv
    Garascia, Andrea
    Van Craenenbroeck, Emeline M.
    Hirose, Kaoru
    Isotani, Akihiro
    Murohara, Toyoaki
    Arita, Yoh
    Sionis, Alessandro
    Fabris, Enrico
    Hashem, Sherin
    Garcia-Hernando, Victor
    Oliva, Fabrizio
    Greenberg, Barry
    Shimokawa, Hiroaki
    Sinagra, Gianfranco
    Adler, Eric D.
    Frigerio, Maria
    Camici, Paolo G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (03) : 299 - 311
  • [42] The Prevalence and Predictors of Atherosclerotic Coronary Artery Disease in Rheumatic and Non-rheumatic Valvular Heart Disease Patients
    Shafi, Shahida
    Aouabdi, Sihem
    Taher, Ziad A.
    Alghamdi, Abdulrahman E.
    Ahmed, Mohammed A.
    Ahmed, Fatima A.
    Alghamdi, Suliman
    Haneef, Ali
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [43] Giant left atrium in rheumatic heart disease
    Bhasin, Dinkar
    Sharma, Yash Paul
    Yadav, Mayank
    Sharma, Arun
    ACTA CARDIOLOGICA, 2024, 79 (02) : 235 - 237
  • [44] Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology
    Gasiorek, Paulina
    Sakowicz, Agata
    Banach, Maciej
    von Haehling, Stephan
    Bielecka-Dabrowa, Agata
    DISEASE MARKERS, 2019, 2019
  • [45] Case Report: Three cases of clinically suspected viral myocarditis with recovery of left ventricular dysfunction
    Brown, Jonathan
    Rashid, Hytham
    Sarva, Siva T.
    Tatapudi, Suhas
    Kalathoor, Jeby
    Srinivasan, Aswin
    Daniel, Michael
    Raza, Syed
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [46] A prospective survey of patients with valvular heart disease in Europe:: The Euro Heart Survey on Valvular Heart Disease
    Iung, B
    Baron, G
    Butchart, EG
    Delahaye, F
    Gohlke-Bärwolf, C
    Levang, OW
    Tornos, P
    Vanoverschelde, JL
    Vermeer, F
    Boersma, E
    Ravaud, P
    Vahanian, A
    EUROPEAN HEART JOURNAL, 2003, 24 (13) : 1231 - 1243
  • [47] Enterovirus replication in valvular tissue from patients with chronic rheumatic heart disease
    Li, Y
    Pan, Z
    Ji, Y
    Peng, T
    Archard, LC
    Zhang, H
    EUROPEAN HEART JOURNAL, 2002, 23 (07) : 567 - 573
  • [48] Coconut Atrium in Long-Standing Rheumatic Valvular Heart Disease
    Onishi, Takahisa
    Idei, Yuka
    Otsui, Kazunori
    Iwata, Sachiyo
    Suzuki, Atsushi
    Ozawa, Toru
    Domoto, Koji
    Takei, Asumi
    Inamoto, Shinya
    Inoue, Nobutaka
    AMERICAN JOURNAL OF CASE REPORTS, 2015, 16 : 191 - 195
  • [49] Rheumatic and nonrheumatic valvular heart disease - Epidemiology, management, and prevention in Africa
    Essop, MR
    Nkomo, VT
    CIRCULATION, 2005, 112 (23) : 3584 - 3591
  • [50] Improvement but no cure of left ventricular systolic dysfunction in treated heart failure patients
    Murphy, Niamh F.
    O'Loughlin, Christina
    Ledwidge, Mark
    McCaffrey, Dennot
    McDonald, Kenneth
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (12) : 1196 - 1204